What happens when cutting-edge nanoscience meets the future of healthcare? In this episode of Oxford+, host Susannah de Jager sits down with Professor Dame Molly Stevens, a globally recognised leader in bionanoscience, to explore the vast potential of interdisciplinary research in transforming medicine. Having recently moved her 87-person research team from Imperial College London to Oxford, Molly shares her insights on the city's unique ecosystem for scientific advancement, the critical role of translational research, and her journey from academic research to entrepreneurship. This episode is an inspiring deep dive into how science and business intersect to drive medical breakthroughs.
Professor Dame Molly Stevens is the John Black Professor of Bionanoscience at the University of Oxford and a part-time professor at Imperial College London and the Karolinska Institute. She is a globally recognised expert in biomaterial interfaces, diagnostics, and regenerative medicine. She plays a key role in advancing translational science as Co-Director of the Kavli Institute for Nanoscience Discovery and the UK Quantum Biomedical Sensing Research Hub. She is also a serial entrepreneur, having founded several biotech companies, and actively advises venture capital firms and start-ups.